Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Bayer: Clinical Trials & FDA Approval Profile

Bayer (Leverkusen, DE / Whippany, NJ) sponsors 107 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 25 active protocols (13 recruiting now), 66 completed protocols, and 98 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)14.9%
Median Closed Enrollment vs National (145 pts)153 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Bayer
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)107
Active Pipeline (Recruiting Now)25 (13)
Completed vs Stopped Early66 / 16 (14.9%)
Median Closed Actual Enrollment153 participants
Physical Hospital Site Disclosure99.7% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals98 (9 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Bayer
Hospital Research SiteLocationShared Protocols
National Taiwan University HospitalTaipei16
Taipei Veterans General HospitalTaipei15
Taichung Veterans General HospitalTaichung14

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Bayer
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07450599A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men WPhase IIRECRUITING
NCT07811193A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With AdvaPhase IIRECRUITING
NCT05457283A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin RecePhase IIIRECRUITING
NCT07192952A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young AdultsPhase IIIRECRUITING
NCT07188805A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to PlacePhase IIIRECRUITING

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Bayer across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the Bayer Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI